The Chemours Company (CC) vs Innospec Inc. (IOSP)
The Chemours Company and Innospec Inc. are both Specialty Chemicals companies. Innospec Inc. is the larger, with a market value of $2.4B against $2.1B — 1.1× the size. The Chemours Company has negative trailing earnings, so its P/E is not meaningful; Innospec Inc. trades at 20.1×. Innospec Inc. grew revenue faster over the last twelve months: 2.87% against −0.89%. Innospec Inc. has the higher net margin (6.60% vs −5.24%) and the higher return on invested capital (7.32% vs −2.22%). Both pay a dividend; The Chemours Company yields more (3.32% vs 1.19%). Across the 21 metrics below, Innospec Inc. leads on 14 and The Chemours Company on 7.
Valuation
Profitability
| Metric | CC | IOSP | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 15.28% | 27.46% | 29.23% |
| Operating margin | (1.93%) | 7.00% | 3.63% |
| Net margin | (5.24%) | 6.60% | 2.89% |
| Free cash flow margin | 3.76% | 2.79% | 3.78% |
| Return on equity | (318.32%) | 9.16% | 3.62% |
| Return on assets | (4.15%) | 6.65% | 0.35% |
| Return on invested capital | (2.22%) | 7.32% | 2.75% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack